Reshaping psoriasis topical therapy: Continuous hydrogenation orchestrates ‘redox-metabolic homeostasis’ for efficient remission and relapse intervention.
Lanmei Lin, Qingqing Guan, Zhiguang Ding, Jianxin Zou, Canbin Dong, Xinyi Zhu, Weijian Fan, Han Li, Jinhua Xu, Jinyun Tan, Wenjiang Ding, Jia Pei, Juan Du · Bioactive materials · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In a laboratory model, demonstrate marked alleviation of psoriasis-like pathologies with this local hydrogen treatment in vitro and in vivo, revealing superior efficacy compared to both Imiquimod-induced mice model and clinical Calcipotriol drug. The authors concluded that consequently, an unmet need remains for topical agents that concurrently target these tripartite pathogenic mechanisms while demonstrating high efficacy, safety, and tolerability to achieve lesion clearance and prevent recurrence. These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
What the Findings Mean
H2HUBB reviewed how molecular hydrogen was evaluated in this publication and summarizes the source-grounded findings below. demonstrate marked alleviation of psoriasis-like pathologies with this local hydrogen treatment in vitro and in vivo, revealing superior efficacy compared to both Imiquimod-induced mice model and clinical Calcipotriol drug.
What the Researchers Studied
The study used a in vitro cell-culture laboratory experiment. The comparison condition was control condition or baseline measurements.
What Effects Did Molecular Hydrogen Have?
Reported treatment duration: 5 min. demonstrate marked alleviation of psoriasis-like pathologies with this local hydrogen treatment in vitro and in vivo, revealing superior efficacy compared to both Imiquimod-induced mice model and clinical Calcipotriol drug. The authors concluded that consequently, an unmet need remains for topical agents that concurrently target these tripartite pathogenic mechanisms while demonstrating high efficacy, safety, and tolerability to achieve lesion clearance and prevent recurrence. Mechanistically, the researchers disclose continuous hydrogenation directly suppresses psoriatic keratinocyte hyperproliferation via anti-Warburg effect and energy metabolic reprogramming through the PKM2-mediated pathway, and meanwhile coordinating redox homeostasis restoration which further disrupts the inflammation-immune feedback loop.
Why These Findings Matter
These findings from a laboratory model add evidence supporting molecular hydrogen's biological and therapeutic potential in the model studied.
How Strong Is This Evidence?
This is laboratory evidence from a in vitro cell-culture laboratory experiment. It is most informative for the biological mechanisms, cellular responses, or biochemical outcomes directly measured.
Technical Study Details
H2HUBB classifies this publication as laboratory study with laboratory or cellular evidence. The reported sample size was 11. The study used a in vitro cell-culture laboratory experiment. The reported treatment duration was 5 min.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.